Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-03-17 @ 3:27 AM
Study NCT ID:
NCT04421560
Status:
RECRUITING
Last Update Posted:
2025-09-03
First Post:
2020-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
Sponsor:
Organization: